California SB 964 allows providers to adjust prescription drug doses without prior authorization
August 30, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This change reduces the administrative burden on patients and providers by bypassing standard insurance approval processes for dose adjustments, potentially speeding up access to medically necessary medication changes.
Potentially affected actors named in the source documents. Mention is not a position.
Health care service plan enrollees
Patients may receive dose or frequency adjustments to their prescriptions without the standard prior authorization process.
Health care service plans
Plans must process adjustment requests within 72 hours and face potential criminal liability for willful violations.
Treating contracting providers
Providers gain the authority to submit written requests for dose or frequency adjustments without prior authorization.
Last recorded activity August 30, 2026.
Introduced.
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Why It Matters
This change reduces the administrative burden on patients and providers by bypassing standard insurance approval processes for dose adjustments, potentially speeding up access to medically necessary medication changes.
Frequently Asked Questions
Does this bill apply to all health insurance plans?
How quickly must my insurance company respond to a dose adjustment request?
News Coverage
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Exemption from Utilization Management
The bill creates a specific carve-out for dose adjustments, signaling a legislative preference for provider-led clinical decisions over insurer-led utilization review in this specific context.
Connected Entities
Sources
openstates.org
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools